Literature DB >> 22577476

Atrial fibrillation: its prevalence and risk factor profile in the German general population.

Renate B Schnabel1, Sandra Wilde, Philipp S Wild, Thomas Munzel, Stefan Blankenberg.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is an increasingly common problem in primary care, but little is known about its prevalence and the distribution of AF risk factors in the general population.
METHODS: We determined the prevalence of AF and the distribution of known AF risk factors among persons participating in the population-based Gutenberg Health Study. To this end, we used interview data about the medical diagnosis of AF and electrocardiograms (ECGs) that were performed for the study in 5000 persons aged 35 to 74. The response rate was 60.4%.
RESULTS: There were 5000 persons in the study sample (age 52.2 ± 11 years; 50.6% were women). The prevalence of AF, weighted for the age and sex distribution of the general population, was 2.5%. AF was found to be more common in older persons, with a more pronounced increase in men: whereas its prevalence was 0.7% in 35- to 44-year-old men, the corresponding figure for the age group 65- to 74 was as high as 10.6%. Twenty five participants (15.5% of AF cases) received their initial diagnosis of AF on the basis of the study ECG. Compared to persons without AF, persons with AF were older and more commonly male, and they had a higher burden of cardiovascular risk factors. 14.3% of persons with AF had none of the well-established risk factors for AF (systolic blood pressure, antihypertensive medication, increased body-mass-index, heart failure). 42.7% of persons with AF were not taking either anticoagulants or platelet inhibitors.
CONCLUSION: These data indicate that the prevalence of AF in the middle-aged general population is 2.5% overall, and higher in the elderly. AF is thus a significant public health problem, and greater awareness of it is needed.

Entities:  

Mesh:

Year:  2012        PMID: 22577476      PMCID: PMC3349225          DOI: 10.3238/arztebl.2012.0293

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  27 in total

Review 1.  Atrial fibrillation: established and innovative methods of evaluation and treatment.

Authors:  Hans-Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2012-01-09       Impact factor: 5.594

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections.

Authors:  Hrafnhildur Stefansdottir; Thor Aspelund; Vilmundur Gudnason; David O Arnar
Journal:  Europace       Date:  2011-05-07       Impact factor: 5.214

4.  Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.

Authors:  Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

5.  Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries.

Authors:  Emy Holstenson; Anna Ringborg; Peter Lindgren; Florence Coste; Francoise Diamand; Robby Nieuwlaat; Harry Crijns
Journal:  Europace       Date:  2010-09-07       Impact factor: 5.214

6.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.

Authors:  Donald M Lloyd-Jones; Thomas J Wang; Eric P Leip; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Ralph B D'Agostino; Joseph M Massaro; Alexa Beiser; Philip A Wolf; Emelia J Benjamin
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

8.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272

10.  Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Authors:  Thomas Meinertz; Wilhelm Kirch; Ludger Rosin; David Pittrow; Stefan N Willich; Paulus Kirchhof
Journal:  Clin Res Cardiol       Date:  2011-05-01       Impact factor: 5.460

View more
  33 in total

1.  The prevalence of amblyopia in Germany: data from the prospective, population-based Gutenberg Health Study.

Authors:  Heike M Elflein; Susanne Fresenius; Julia Lamparter; Susanne Pitz; Norbert Pfeiffer; Harald Binder; Philipp Wild; Alireza Mirshahi
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

2.  [Atrial fibrillation].

Authors:  R R Tilz; K H Kuck
Journal:  Herz       Date:  2015-02       Impact factor: 1.443

3.  Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies.

Authors:  Andreas D Meid; Sarah Mächler; Walter E Haefeli; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2017-07-21       Impact factor: 4.335

4.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

Authors:  Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

Review 5.  [Electrical isolation of the left atrial appendage : Benefits and risks].

Authors:  B Bellmann; R R Tilz; A Rillig
Journal:  Herz       Date:  2017-06       Impact factor: 1.443

Review 6.  Biological functions of the ING family tumor suppressors.

Authors:  E I Campos; M Y Chin; W H Kuo; G Li
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

7.  Experience matters: long-term results of pulmonary vein isolation using a robotic navigation system for the treatment of paroxysmal atrial fibrillation.

Authors:  Andreas Rillig; Tina Lin; Boris Schmidt; Britta Feige; Christian Heeger; Jascha Wegner; Erik Wissner; Andreas Metzner; Anita Arya; Shibu Mathew; Peter Wohlmuth; Feifan Ouyang; Karl-Heinz Kuck; Roland Richard Tilz
Journal:  Clin Res Cardiol       Date:  2015-07-22       Impact factor: 5.460

Review 8.  Biological Therapies for Atrial Fibrillation: Ready for Prime Time?

Authors:  J Kevin Donahue
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

9.  [Therapeutic management of non-valvular atrial fibrillation. Update 2013].

Authors:  K Bode; P Sommer; A Bollmann; G Hindricks
Journal:  Herz       Date:  2013-11       Impact factor: 1.443

10.  Systematic Screening for Atrial Fibrillation in the Community: Evidence and Obstacles.

Authors:  Ngai-Yin Chan
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.